IVOSIDENIB for Chondrosarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where IVOSIDENIB was used for Chondrosarcoma.
Most Reported Side Effects for IVOSIDENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 613 | 36.2% | 31 | 96 |
| Fatigue | 144 | 8.5% | 6 | 17 |
| Diarrhoea | 100 | 5.9% | 4 | 17 |
| Nausea | 100 | 5.9% | 5 | 27 |
| Disease progression | 86 | 5.1% | 19 | 9 |
| Differentiation syndrome | 80 | 4.7% | 22 | 46 |
| Product dose omission issue | 68 | 4.0% | 0 | 16 |
| Drug ineffective | 64 | 3.8% | 12 | 13 |
| Platelet count decreased | 61 | 3.6% | 3 | 27 |
| Electrocardiogram qt prolonged | 58 | 3.4% | 3 | 19 |
| Pneumonia | 51 | 3.0% | 9 | 40 |
| Vomiting | 51 | 3.0% | 4 | 26 |
| Asthenia | 49 | 2.9% | 6 | 17 |
| Febrile neutropenia | 48 | 2.8% | 7 | 43 |
| Product use issue | 43 | 2.5% | 4 | 13 |
Other Indications for IVOSIDENIB
Acute myeloid leukaemia (729)
Cholangiocarcinoma (277)
Product used for unknown indication (194)
Brain neoplasm malignant (140)
Myelodysplastic syndrome (65)
Off label use (27)
Astrocytoma (20)
Bone cancer (19)
Glioma (16)
Bile duct cancer (15)
Other Drugs Used for Chondrosarcoma
CABOZANTINIB S-MALATE (146)
DOXORUBICIN (42)
PAZOPANIB (32)
IFOSFAMIDE (28)
CISPLATIN (22)
VISMODEGIB (19)
NIVOLUMAB (17)
BELINOSTAT (12)
CYCLOPHOSPHAMIDE (11)
METHOTREXATE (10)